Page 1 of Clinical Trials for Dana-Farber Cancer Institute [SPONSOR-COLLABORATORS], 539 Total Matches
- 1RecruitingLast Updated: July 20, 2011Condition(s): Multiple Myeloma
- 2Active, not recruitingLast Updated: December 20, 2007Condition(s): Multiple Myeloma
- 3Active, not recruitingLast Updated: October 11, 2011Condition(s): Endometrial Cancer
- 4RecruitingLast Updated: February 15, 2012Condition(s): Prostate Cancer
- 5Active, not recruitingLast Updated: March 10, 2012Condition(s): Cancer
- 6RecruitingLast Updated: January 19, 2012Condition(s): Non-hodgkin Lymphoma; Hodgkin Lymphoma
- 7Active, not recruitingLast Updated: February 21, 2012Condition(s): Colorectal Cancer
- 8Active, not recruitingLast Updated: February 24, 2012Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- 9CompletedLast Updated: December 26, 2010Condition(s): Brain and Central Nervous System Tumors; Gastrointestinal Stromal Tumor; Sarcoma
- 10Active, not recruitingLast Updated: April 30, 2012Condition(s): Drug/Agent Toxicity by Tissue/Organ; Leukemia
- 11RecruitingLast Updated: April 25, 2012Condition(s): Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
- 12Active, not recruitingLast Updated: October 30, 2009Condition(s): Breast Cancer; Ovarian Cancer
- 13Active, not recruitingLast Updated: March 19, 2012Condition(s): Lung Cancer
- 14Active, not recruitingLast Updated: October 25, 2011Condition(s): Acute Lymphoblastic Leukemia
- 15CompletedLast Updated: July 6, 2011Condition(s): Brain and Central Nervous System Tumors; Neuroblastoma
- 16RecruitingLast Updated: May 15, 2012Condition(s): Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma
- 17CompletedLast Updated: March 28, 2012Condition(s): Hematologic Malignancy
- 18Active, not recruitingLast Updated: December 6, 2011Condition(s): Sarcoma
- 19RecruitingLast Updated: January 23, 2012Condition(s): Chronic Graft-versus-host Disease
- 20Enrolling by invitationLast Updated: August 11, 2011Condition(s): Health Behavior; Risk Reduction Behavior
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Dana-Farber+Cancer+Institute
